Ingredion Inc beats Q2 sales estimates, reaffirms 2026 guidance
INGR•Segment performance and analyst context
Ingredion said Texture & Healthful Solutions delivered net sales volume growth, supported by strong customer demand for clean-label and other solutions offerings.
Food & Industrial Ingredients—U.S./CAN operating income declined due to lower production at the Argo facility and softer volumes and price mix, though production rates normalized by quarter-end. Food & Industrial Ingredients—LATAM operating income decreased, mainly because of Mexico’s transactional currency impacts and a more challenging demand environment.
The company also noted progress on the Tate & Lyle acquisition.
Wall Street's median 12-month price target for Ingredion is $120.00, about 19.5% above its August 3 closing price of $100.42. The stock recently traded at 9 times the next 12-month earnings, versus a P/E of 10 three months ago.
Q2 sales beat estimates as EPS edged lower
Ingredion Inc reported second-quarter sales of $1.85 billion, beating analyst expectations of $1.83 billion and rising 1% from a year earlier.
Adjusted EPS for the quarter fell slightly to $2.82.
2026 outlook reaffirmed
Ingredion reaffirmed its full-year guidance for 2026, including reported EPS of .
